Skip to content
Clinical Trials – home
Itb-Med AB
Sponsor

Itb-Med AB

Sweden Hagaplan 4, 113 68 Stockholm, Sweden

About the sponsor

Itb-Med AB funds clinical research in renal transplantation and liver transplantation, with a strong focus on preventing graft rejection and supporting immune compatibility after organ replacement.

  • Kidney transplant rejection prevention
  • Liver allograft tolerance
  • Allogeneic immune regulation

The sponsor’s transplant portfolio centers on immunomodulatory therapy in recipients of deceased-donor organs and other post-transplant settings.

About Specializations

Itb-Med AB runs clinical trials in conditions such as Prophylaxis against transplant rejection, Type 1 diabetes mellitus, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Study on Siplizumab, Cyclophosphamide, and Splenectomy for Preventing Liver Transplant Rejection in Patients Receiving a Deceased Donor Liver

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Siplizumab
  • Sponsor:Itb-Med AB

Study on Siplizumab and Rabbit Anti-Thymocyte Globulin for Preventing Rejection in New Kidney Transplant Patients

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Itb-Med AB

Study on the Effects of Siplizumab in Adults with New Onset Type 1 Diabetes

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Paracetamol
  • Sponsor:Itb-Med AB

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.